Heat Biologics, Inc.
Heat Biologics, Inc. (HTBX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HTBX · as of Jun 9, 2026
Key Statistics
Explore Heat Biologics, Inc. Data
htbx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 100.0%
Competitors & Peers
htbx competitorsHTBX
ACHL
ALVR
HYFT
KRON
QNCXStock Performance
Full HistoryAbout Heat Biologics, Inc.
Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety…
what is heat biologics, inc. · htbx stock overview · heat biologics, inc. company profile · who is heat biologics, inc. ceo · htbx AMEX · heat biologics, inc. headquarters · heat biologics, inc. business segments
About Stock Overview & Key Data
Heat Biologics, Inc. (HTBX) is a Healthcare company in the Biotechnology industry, listed on AMEX since Jul 24, 2013. As of the latest trading session, HTBX stock price is $2.38, with a market capitalization of $61.1M. The stock has returned -11.52% over the past 12 months and +0.00% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Heat Biologics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2021, Heat Biologics, Inc. reported revenue of $2.1M and net income of -$35.4M. For detailed data — including Heat Biologics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Heat Biologics, Inc. (HTBX) stock price is $2.38. The stock is traded on AMEX under the ticker symbol HTBX. The 52-week range is $2.33 – $2.48.